- BioDue is an Italian company that develops, manufactures and commercialises food supplements, medical devices and cosmetics
- Riverside has identified several add-on targets for BioDue, which are under evaluation
- BioDue was founded in 1986 by the Benedetti family
The Riverside Company announced it has signed a definitive agreement to acquire a controlling stake in BioDue, an Italian company that develops, manufactures and commercialises food supplements, medical devices and cosmetics.
BioDue, based in Sambuca, provides customers with a full-service offering, ranging from raw material sourcing development and formulation, through production, packaging, and regulatory affairs, to commercialisation.
Riverside plans to pursue a pan-European buy-and-build strategy with BioDue, and the firm has already identified several add-on targets, currently under evaluation. Additionally, the firm will seek to enhance BioDue’s “one-stop-shop” offering and expand its breadth of product ranges across galenic forms and therapeutic areas.
“BioDue brings in-house R&D and lab analysis capabilities, as well as well-run, state-of-the-art production sites with excess capacity,” said Rafael Alvarez-Novoa, partner of Riverside Europe. “In addition to pursuing add-on acquisitions and helping the business develop its product range, we also plan to enhance BioDue’s commercial approach to accelerate sales growth, and drive operational excellence.”
The Riverside Company, headquartered in New York, is a global private equity firm focused on investing in growing businesses valued at up to $400 million.